Cat. No. 3541
Chemical Name: (R)-α-Cyclopentyl-4-(2-quinolinylmet
Biological Activity5-lipoxygenase activating protein (FLAP) inhibitor. Inhibits the synthesis of leukotrienes B4 and C4 in animal models; inhibits synthesis of leukotriene B4 in A23187-stimulated leukocytes (IC50 values are 0.026, 0.039 and 0.22 μM for rat, mice and human leukocytes respectively). Displays anti-inflammatory activity. Orally active.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Hatzelmann et al (1994) Mode of action of the leukotriene synthesis (FLAP) inhibitor BAY X 1005: implications for biological regulation of 5-lipoxygenase. Agents Actions 43 64. PMID: 7741044.
Fruchtmann et al (1993) In vitro pharmacology of BAY X1005, a new inhibitor of leukotriene synthesis. Agents Actions 38 188. PMID: 8213345.
Muller-Peddinghaus et al (1993) BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics. J.Pharmacol.Exp.Ther. 267 51. PMID: 8229782.
If you know of a relevant reference for BAY-X 1005 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses BAY-X 1005 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: BAY-X 1005, supplier, BAY-X1005, 5-lipoxygenase, activating, protein, FLAP, inhibitors, inhibits, leukotriene, synthesis, signaling, signalling, inhibitors, inhibits, antiinflammatory, 5-LOX, Tocris Bioscience, Lipoxygenase Inhibitor products
Find multiple products by catalog number
August 20 - 24, 2017
Paris , France